The $50 Proteome.

1000 of the most informative proteins, quantified at high fidelity — in a platform designed to be broadly applicable, and engineered to be radically affordable.

The only seamless end to end service to democratize proteomics for any study

471,796+

Samples profiled

92,632,367+

Proteins profiled

100+

Institutions supported

1000

Proteins in library

Making Proteomics Ubiquitous

How the Nomic platform is bringing about affordable, flexible and quantitative proteomics.

True Multiplexing at Scale

Re-engineering the sandwich immunoassay for scale and efficiency using DNA as a flexible, programmable linker.

Solutions that adapt to your science, not the other way around

Omni 1000

Discover using 1000 of the most informative proteins in one product with absolute quantification, expertly curated to balance the critical must-haves, proteome-wide breadth, and real-world utility.

Core

Perform targeted discovery using context-specific, ~300-protein panels that bring together the most important proteins for that area.

Flex

À la carte selection of markers from the full library. Building a custom panel that is aligned with your study goals, without the usual restrictions.

Accessible. Adaptable. Absolute.

Achieve multiplexing at-scale, minus the usual barriers.

High Fidelity

True multiplexing enables high sensitivity and exquisite specificity—at scale.

Flexible

Build your ideal panel à la carte—select only the proteins you need, without the usual constraints.

Absolute Quantification

Broad profiling with absolute quantification means consistent precision, with <10% intra-lot CV.

Cost-Efficient

Affordable protein profiling for larger scale studies and broader impact.

Rapid Turnaround Time

Data in days, not months—on your needed timeline, even for thousands of samples.

Accelerated Analysis

Intuitive analysis tools turn high-dimensional data into fast, actionable insights.

Fast, High-Throughput Service Backed by Expert Support

The world’s fastest and most seamless protein profiling service—built on nELISA, powered by automation, and backed by experts—with turnaround times as fast as one week.

nELISA by the numbers

~0.1 pg/mL​

High-sensitivity​
assays​

<10% CV​

Intra-lot reproducibility

3-6 log​

Per assay
dynamic range​

99.99%​

Specificity​

High Throughput​

Tens of thousands of samples per week​

Cost Efficient​

Low cost per sample​

Plain light gray background with uniform texture and neutral color

"Nomic’s platform provides an elegant and scalable solution, delivering robust data at a quality-to-cost ratio that’s unmatched. Beyond validating known targets, the platform helped us uncover previously unappreciated soluble components involved in response to cancer immunotherapy. These findings are now guiding new research directions. We absolutely recommend Nomic to others in the field—it’s been a transformative addition to our research toolkit.”

Lloyd Bod, MS, PhD
Principal Investigator @ Mass General Hospital Cancer Center

“Nomic has an outstanding analysis suite, with a great support team who will jump on a call and guide you through all its organizational and graphing capacities, and unmatched comprehensiveness with hundreds of cytokines and other soluble factors all measured at once, really maximizing the information obtained from precious samples.”

Leonardo M. R. Ferreira, PhD
Assistant Professor of Pharmacology & Immunology
Medical University of South Carolina

"Nomic’s platform provides an elegant and scalable solution, delivering robust data at a quality-to-cost ratio that’s unmatched. Beyond validating known targets, the platform helped us uncover previously unappreciated soluble components involved in response to cancer immunotherapy. These findings are now guiding new research directions. We absolutely recommend Nomic to others in the field—it’s been a transformative addition to our research toolkit.”

Lloyd Bod, MS, PhD
Principal Investigator
Mass General Hospital Cancer Center

“The nELISA has transformed our capabilities and is the primary data stream for our high throughput in vitro and ex vivo experiments. The data dimensionality, quality and turnaround time far surpasses anything we could achieve in house ourselves.”

Sarah Headland, PhD
Director, Head of Biology
Sound Biologics

Upcoming Events

November 5, 2025
November 9, 2025

SITC 2025

November 2, 2025
November 5, 2025

ICIS Cytokines 2025

October 15, 2025
October 15, 2025

Currents of Pan-Cancer: Insights from 1,000 Circulating Proteins

November 9, 2025
November 13, 2025
Westin Harbour Castle, Toronto, ON, Canada

24th Human Proteome Organization World Congress 2025 (HUPO)

Plain light gray background with uniform texture and neutral color

Latest Press

September 4, 2025

Nomic Bio Awards Omni 1000 Proteomics Grants to Seven Institutions, Enabling 5 Million Data Points Across 5,000 Samples

May 13, 2025

Omni 1000 Grant Opportunity in High Plex Proteomics

May 13, 2025

Nomic Bio Debuts $50 Proteome with Absolute Quantification Through Launch of Omni 1000

September 24, 2024

Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study

December 8, 2021

Nomic Closes $17 Million Series A to Develop and Commercialize the World’s Highest Throughput Proteomic Platform

June 28, 2023

Nomic Bio Appoints Byron Hewett to its Board of Directors

December 8, 2021

Nomic to Provide nELISA to JUMP Cell Painting Consortium to Measure Protein Secretome for Phenotypic Drug Discovery

September 17, 2024

Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling

January 3, 2025

Bridging the Gaps in Proteomics

Get the latest in proteomics, straight to your inbox

Be the first to hear about new targets, product updates, data highlights, and upcoming events.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Network connections and data points on a vibrant blue background